Philadelphia Treatment Court
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT01481428
This study will be the first to examine the efficacy of using a brief, computerized HIV risk reduction intervention in treatment courts.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Philadelphia, Pennsylvania, 19107, United States
Four hundred consenting treatment drug court participants will be randomly assigned to either an HIV intervention group (n = 200) or an attention control group. All clients will attend their regularly scheduled status hearings which are scheduled approximately every six weeks. Clients in the HIV intervention group will receive a brief computerized, self-administered HIV risk reduction intervention following each of their first three status hearings. Clients in the attention control condition will view a series of educational life-skill videos of matched length following each of their first three status hearings. The primary outcome will be engagement in high risk behaviors as measured by the Risk Assessment Battery (RAB). Secondary HIV-related outcomes will include: (1) rate of HIV testing, (2) condom procurement, and (3) self-reported condom use. Tertiary outcomes related to treatment court compliance will include: (1) drug court graduation, (2) urinalysis-confirmed drug abstinence, (3) case management attendance, and (4) satisfaction with case management. In addition, we will conduct preliminary cost and cost-effectiveness analyses on the delivery of the brief computerized HIV intervention. Assessments will be conducted at baseline and 9- and 15-months post admission.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individuals assigned to the experimental condition will complete the self-directed CARE HIV intervention during each of their first three sessions. The 20 minute intervention sessions involve several components including a brief risk assessment, review of identified risks, structured skill building videos, and the development of a risk prevention action plan. Because of the adaptive nature of the CARE program, the content of each session will be tailored to address the current risks of the participant. While the main focus of the intervention is on risk, individuals who report being HIV infected will receive a referral to treatment if they are not currently receiving medical care and their session will address, among other things, adherence to HIV care.
Life skills training DVDs that match the duration of the anticipated experimental condition. The DVDs address topics such as positive listening skills, anger management, and stress reduction.
Time frame: 15 month follow-up
Measured by the Risk Assessment Battery (RAB)
Time frame: 15 month follow-up
Time frame: 15 month follow-up
Time frame: 15 month follow-up
Treatment Research Institute
Other
Delivering HIV Risk Reduction Services in Treatment Court
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01235091
Chemically-Induced Disorders, Communicable Diseases
View Trial DetailsNCT01497405
Chemically-Induced Disorders, Communicable Diseases
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT02677025
Chemically-Induced Disorders, Communicable Diseases
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT02733003
Chemically-Induced Disorders, Communicable Diseases
Research Triangle Park, North Carolina, United States
View Trial Details